- Home
- OPRT vs HUMA Comparison
OPRT vs HUMA Comparison
Compare OPRT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRT
- HUMA
- Stock Information
- Founded
- OPRT 2005
- HUMA 2004
- Country
- OPRT United States
- HUMA United States
- Employees
- OPRT N/A
- HUMA N/A
- Industry
- OPRT Finance: Consumer Services
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- OPRT Finance
- HUMA Health Care
- Exchange
- OPRT Nasdaq
- HUMA Nasdaq
- Market Cap
- OPRT 221.5M
- HUMA 221.8M
- IPO Year
- OPRT 2019
- HUMA N/A
- Fundamental
- Price
- OPRT $6.71
- HUMA $1.19
- Analyst Decision
- OPRT Hold
- HUMA Strong Buy
- Analyst Count
- OPRT 2
- HUMA 6
- Target Price
- OPRT $5.00
- HUMA $14.60
- AVG Volume (30 Days)
- OPRT 323.1K
- HUMA 2.8M
- Earning Date
- OPRT 05-08-2025
- HUMA 05-13-2025
- Dividend Yield
- OPRT N/A
- HUMA N/A
- EPS Growth
- OPRT N/A
- HUMA N/A
- EPS
- OPRT N/A
- HUMA N/A
- Revenue
- OPRT $746,117,000.00
- HUMA N/A
- Revenue This Year
- OPRT $28.71
- HUMA N/A
- Revenue Next Year
- OPRT $9.89
- HUMA $1,178.20
- P/E Ratio
- OPRT N/A
- HUMA N/A
- Revenue Growth
- OPRT N/A
- HUMA N/A
- 52 Week Low
- OPRT $2.37
- HUMA $1.15
- 52 Week High
- OPRT $9.25
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- OPRT 71.62
- HUMA 29.75
- Support Level
- OPRT $4.77
- HUMA $1.35
- Resistance Level
- OPRT $5.68
- HUMA $1.26
- Average True Range (ATR)
- OPRT 0.34
- HUMA 0.09
- MACD
- OPRT 0.21
- HUMA 0.03
- Stochastic Oscillator
- OPRT 75.36
- HUMA 2.78
About OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.